Home News

ROVI and the EIB agreement

ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies

Thu, 21/12/2017 - 18:33 0 min
No votes yet
 
Related
Presentation of results for the first quarter of 2017
0 min
21/04/2017
The biosimilar Enoxaparin, a great opportunity for ROVI
“La historia de ROVI está unida a las heparinas desde nuestros inicios, por lo que este biosimilar de enoxaparina es una evolución lógica...
1 min
13/03/2017
Presentation on the biosimilar Enoxaparin of ROVI
0 min
13/03/2017